3382 Results

People

  1. Hudis
    Hudis
  2. Soslow
    Soslow
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Motzer
    Motzer
  6. Rusch
    Rusch
  7. Patil
    Patil
  8. Barakat
    Barakat
  9. Kris
    Kris
  10. Scher
    Scher

Groups

  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)
  7. Department of Pathology and Laboratory Medicine (408)
  8. Center for Hematologic Malignancies (395)
  9. Epidemiology and Biostatistics (369)
  10. Hematologic Malignancies, Division of (342)
  1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Tagawa, S. T.; Saran, A.; Akhtar, N. H.; Goel, S.; Mileo, G.; Kung, S.; Beltran, H.; Milowsky, M. I.; Mazumdar, M.; Wright, J. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience
    Meeting Abstract

    Smyth, E. C.; Enzinger, P. C.; Li, J.; Vincitore, M.; Lacy, J.; El-Rayes, B. F.; Kunz, P. L.; Ford, J. M.; Robinson, E.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL
    Meeting Abstract

    Shepard, D. D.; Kohrt, H. E.; Rosenblat, T. L.; Jurcic, J. G.; Park, J. H.; Goldman, A.; Dalal, J. S.; Maslak, P. G.; Jakubowski, A. A.; Klimek, V.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Lymph node (LN) ratio (LNR) risk classification (RC) in stage III colon cancer (CC): A pooled analysis of 16,425 patients from the ACCENT database
    Meeting Abstract

    Shi, Q.; Hubbard, J. M.; Yothers, G. A.; Andre, T.; Saltz, L.; Francini, G.; Bot, B. M.; Twelves, C.; Buyse, M. E.; Grothey, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I dose-escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Final results
    Meeting Abstract

    Slovin, S. F.; Morris, S.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Murphy, D.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147
    Meeting Abstract

    Sloan, J. A.; Mahoney, M. R.; Sargent, D. J.; Hubbard, J. M.; Liu, H.; Basch, E. M.; Shields, A. F.; Chan, E.; Goldberg, R. M.; Gill, S.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Tuttle, R. M.; Ghossein, R. A.; Schòˆder, H.; Baum, M. S.; Kelly, K.; Chen, A. P.; Shaha, A. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial
    Meeting Abstract

    Schwartz, G. K.; Maki, R. G.; Ratain, M. J.; Undevia, S. D.; Jones, R. L.; Rudin, C. M.; Siu, L. L.; Brockstein, B.; Khayat, D.; Gil, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Tesetaxel, an advanced-generation oral taxane, as first-line treatment in women with metastatic breast cancer
    Meeting Abstract

    Schwartzberg, L. S.; Beeram, M.; Patnaik, A.; Tolcher, A. W.; Itri, L.; Olson, A. L.; Seidman, A. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls
    Meeting Abstract

    Shaw, A. T.; Yeap, B. Y.; Solomon, B. J.; Riely, G. J.; Iafrate, A. J.; Shapiro, G.; Costa, D. B.; Butaney, M.; Ou, S. I.; Maki, R. G.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save